PEDIATRIC LATE OUTCOMES PROTOCOL ACTG 219C

儿科晚期结果方案 ACTG 219C

• 批准号: 7607845
• 负责人: Sharon A Nachman
• 金额: $ 11.14万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-03-23 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607845
• 关键词: AIDS clinical trial group; Adolescent; Childhood; Computer Retrieval of Information on Scientific Projects Database; Enrollment; Funding; Grant; Infant; Institution; Mothers; Outcome; Patient currently pregnant; Pharmaceutical Preparations; Protocols documentation; Purpose; Research; Research Personnel; Resources; Site; Source; United States National Institutes of Health; Vaccines; pediatric AIDS

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. ACTG 219c The purpose of this study is to follow all infants, childern and adolescents who are seen at Pediatric AIDS Clinical Trials Group sites as well as infants born to HIV-infected mothers who were enrolled in a PACTG drug study when they were pregnant, to look for long-term benefits or any late, harmful effects of medications or vaccines taken. All childern are eligible to be followed until at least their 24th birthday.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 ACTG 219c 本研究的目的是跟踪在儿科艾滋病临床试验组站点就诊的所有婴儿、儿童和青少年，以及怀孕时参加 PACTG 药物研究的 HIV 感染母亲所生的婴儿，以寻找所服用药物或疫苗的长期益处或任何晚期有害影响。所有儿童都有资格接受追踪，直至其 24 岁生日为止。